Abundance Wealth Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Abundance Wealth Counselors's XBI Position: Q2 2026 in Review
Abundance Wealth Counselors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 29% in Q2 2026, buying an estimated $107K and bringing the position to 3,555 shares worth $562K. The position accounts for 0.04% of the portfolio, ranked #170.
Abundance Wealth Counselors first reported a position in XBI in Q1 2021 and has held it in 14 quarters since. The position peaked at $18M in Q3 2024. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Abundance Wealth Counselors held 3,555 shares of State Street SPDR S&P Biotech ETF worth $562K as of Q2 2026.
- Abundance Wealth Counselors bought 794 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $107K.
- State Street SPDR S&P Biotech ETF made up 0.04% of Abundance Wealth Counselors's portfolio in Q2 2026, its #170 holding.
- Abundance Wealth Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2021 and has held it in 14 quarters since.
- Abundance Wealth Counselors's State Street SPDR S&P Biotech ETF position peaked at $18M in Q3 2024.
- 934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.